...
首页> 外文期刊>Experimental and therapeutic medicine >Analysis of long non-coding RNA expression profiles identifies functional lncRNAs associated with the progression of acute coronary syndromes
【24h】

Analysis of long non-coding RNA expression profiles identifies functional lncRNAs associated with the progression of acute coronary syndromes

机译:长期非编码RNA表达谱的分析识别与急性冠状动脉综合征的进展相关的功能性LNCRNA

获取原文
获取原文并翻译 | 示例
           

摘要

It has been demonstrated that long non-coding RNAs (lncRNAs) are important in the gene regulatory network and their dysregulated expression has been implicated in cardiovascular disease. However, little is known regarding lncRNA expression patterns and their function in the progression of acute coronary syndromes (ACSs). In the present study, the expression profiles of lncRNAs from 52 patients with ACS were analyzed by re-annotating existing microarray data. The lncRNA expression profiles in the two distinct clinical entities of ACS, myocardial infarction (MI) and unstable angina (UA), were examined. Out of the 2,332 lncRNAs assessed, it was identified that 18 lncRNAs were upregulated and 35 lncRNAs were downregulated in patients with MI compared to those with UA. Furthermore, the expression profiles of patients with ACS were compared at different time points and significantly altered lncRNA expression was observed during the progression of ACS. A total of 7 candidate lncRNA biomarkers were identified and an lncRNA-based classifier was developed to predict MI risk based on the expression data of the 7 lncRNAs using random forest and support vector machine strategies. This achieved a classification accuracy of 90.38% with a sensitivity of 100% and a specificity of 68.75%. Additionally, functional analysis suggested that these 7 lncRNAs may be involved in known MI-associated biological processes and pathways.
机译:已经证明,长期的非编码RNA(LNCRNA)在基因调节网络中是重要的,并且它们的失调表达已经涉及心血管疾病。然而,关于LNCRNA表达模式的少量是众所周知的,其在急性冠状动脉综合征(ACSS)的进展中的功能。在本研究中,通过重新注释现有的微阵列数据来分析来自52例ACS患者的LNCRNA的表达谱。检查ACS,心肌梗死(MI)和不稳定心绞痛(UA)的两个不同临床实体中的LNCRNA表达谱。在评估的2,332个LNCRNA中,鉴定出上调18个LNCRNA,与MI的患者相比,将35个LNCRNA与UA相比下调。此外,在不同时间点比较ACS患者的表达谱,并且在ACS进展期间观察到了显着改变的LNCRNA表达。鉴定了总共7个候选LNCRNA生物标志物,并开发了基于LNCRNA的分类器,以通过使用随机森林的7 LNCRNA的表达数据来预测MI风险,并支持向量机策略。这实现了90.38%的分类精度,灵敏度为100%,特异性为68.75%。另外,功能性分析表明,这些7LNCRNA可以参与已知的MI相关的生物过程和途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号